These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3627287)

  • 21. 2-nitroimipramine: a selective irreversible inhibitor of [3H] serotonin uptake and [3H] imipramine binding in platelets.
    Rehavi M; Ittah Y; Rice KC; Skolnick P; Goodwin FK; Paul SM
    Biochem Biophys Res Commun; 1981 Apr; 99(3):954-9. PubMed ID: 7247951
    [No Abstract]   [Full Text] [Related]  

  • 22. Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patients.
    Suranyi-Cadotte BE; Quirion R; Nair NP; Lafaille F; Schwartz G
    Life Sci; 1985 Feb; 36(8):795-9. PubMed ID: 3974410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain.
    Rehavi M; Tracer H; Rice K; Skolnick P; Paul SM
    Life Sci; 1983 Feb; 32(6):645-53. PubMed ID: 6835029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
    Plenge P; Mellerup ET; Laursen H
    Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An assay to measure the simultaneous uptake of [3H]dopamine and [14C]serotonin by the human platelet reveals an imipramine-insensitive [3H]dopamine uptake mechanism.
    Dean B; Copolov DL
    Life Sci; 1992; 50(5):341-7. PubMed ID: 1732705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.
    Poirier MF; Loo H; Benkelfat C; Sechter D; Zarifian E; Galzin AM; Schoemaker H; Segonzac A; Langer SZ
    Eur J Pharmacol; 1984 Nov; 106(3):629-33. PubMed ID: 6097464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the serotonin transporter in platelets.
    Langer SZ; Galzin AM
    Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced uptake of serotonin but unchanged 3H-imipramine binding in the platelets from cirrhotic patients.
    Ahtee L; Briley M; Raisman R; Lebrec D; Langer SZ
    Life Sci; 1981 Nov; 29(22):2323-9. PubMed ID: 7321762
    [No Abstract]   [Full Text] [Related]  

  • 29. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin and dopamine uptake by human blood platelets.
    Airaksinen MM; Svensk H; Tuomisto J; Komulainen H
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):308-13. PubMed ID: 7368950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Iodoimipramine, a novel ligand for the serotonin transporter.
    Humphreys CJ; Cassel D; Rudnick G
    Mol Pharmacol; 1989 Oct; 36(4):620-6. PubMed ID: 2811859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter.
    Wölfel R; Graefe KH
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):129-36. PubMed ID: 1570019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term lithium administration to healthy volunteers produces long-lasting pronounced changes in platelet serotonin uptake but not imipramine binding.
    Poirier MF; Galzin AM; Pimoule C; Schoemaker H; Le Quan Bui KH; Meyer P; Gay C; Loo H; Langer SZ
    Psychopharmacology (Berl); 1988; 94(4):521-6. PubMed ID: 3131797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of endogenous inhibitors of [3H]-imipramine binding and [3H]-serotonin uptake from rat serum.
    Angel I; Goldman ME; Skolnick P; Pisano JJ; Paul SM
    Prog Clin Biol Res; 1985; 192():457-64. PubMed ID: 3001766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelets and biogenic amines. 2. Indications for a discrete low affinity uptake mechanism shared by norepinephrine and 5-hydroxytryptamine in human platelets.
    Malmgren R
    Psychopharmacology (Berl); 1986; 90(3):384-9. PubMed ID: 3097728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of imipramine inhibition of platelet 5-hydroxytryptamine transport.
    Talvenheimo J; Nelson PJ; Rudnick G
    J Biol Chem; 1979 Jun; 254(11):4631-5. PubMed ID: 438209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [3H]citalopram binding to brain and platelet membranes of human and rat.
    Plenge P; Mellerup ET
    J Neurochem; 1991 Jan; 56(1):248-52. PubMed ID: 1824783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetic properties of [3H]2-nitroimipramine binding to human platelets.
    Davis A
    Eur J Pharmacol; 1983 Dec; 96(1-2):105-10. PubMed ID: 6662191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial serotonin transport into viable platelets and imipramine binding to platelet membranes.
    Rao ML; Frahnert C; Zagorski O
    J Neural Transm (Vienna); 2002 May; 109(5-6):547-56. PubMed ID: 12111448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptics and beta-carbolines displace (3H)Imipramine from its binding sites in human and rat tissues.
    Rommelspacher H; Strauss S
    J Neural Transm; 1985; 61(1-2):55-63. PubMed ID: 2858513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.